Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03478514 |
Title | Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Alliance Foundation Trials, LLC. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope National Medical Center | Duarte | California | 91010 | United States | Details | |
University of Maryland, Greenebaum Comprehensive Cancer Center | Baltimore | Maryland | 21201 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
St. Joseph Mercy Hospital Cancer Care Center | Ypsilanti | Michigan | 48197 | United States | Details | |
Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14263 | United States | Details | |
Weill Cornell Medical College | New York | New York | 10065 | United States | Details | |
University of North Carolina | Chapel Hill | North Carolina | 27599 | United States | Details | |
Ohio State University | Columbus | Ohio | 43210 | United States | Details | |
Medical University of South Carolina - Hollings Cancer Center | Charleston | South Carolina | 29425 | United States | Details |